Literature DB >> 1549312

Oral mycoses in HIV infection.

L P Samaranayake1.   

Abstract

Oral mycoses in human immunodeficiency virus (HIV) infection are becoming increasingly common. Of these, oral candidiasis is by far the most prevalent; fewer than 10 cases of cryptococcosis, histoplasmosis, and geotrichosis have thus far been reported. Oral candidiasis is one of the earliest premonitory signs of HIV infection and may present as erythematous, pseudomembranous, hyperplastic, or papillary variants, or as angular cheilitis. Cumulative data from 23 surveys (incorporating 3387 adults) suggest that in general, oral candidiasis may develop in one third to half of HIV-seropositive persons. Almost equal numbers of cases manifest with either erythematous or pseudomembranous variants. These and related concepts pertaining to oral mycoses in HIV infection are reviewed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549312     DOI: 10.1016/0030-4220(92)90191-r

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  47 in total

Review 1.  The significance of oral health in HIV disease.

Authors:  I L Chapple; J Hamburger
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

Review 2.  Human genetic susceptibility to Candida infections.

Authors:  Theo S Plantinga; Melissa D Johnson; William K Scott; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart Jan Kullberg; Mihai G Netea
Journal:  Med Mycol       Date:  2012-06-04       Impact factor: 4.076

3.  Increased risk of mortality and loss to follow-up among HIV-positive patients with oropharyngeal candidiasis and malnutrition before antiretroviral therapy initiation: a retrospective analysis from a large urban cohort in Johannesburg, South Africa.

Authors:  Denise Evans; Mhairi Maskew; Ian Sanne
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-03

4.  Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors.

Authors:  W K Leung; R S Dassanayake; J Y Yau; L J Jin; W C Yam; L P Samaranayake
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  Atypical micromorphology and uncommon location of cryptococcosis: a histopathologic study using special histochemical techniques (one case report).

Authors:  Alexandra Flávia Gazzoni; Cecília Bittencourt Severo; Marines Bizarro Barra; Luiz Carlos Severo
Journal:  Mycopathologia       Date:  2008-12-04       Impact factor: 2.574

6.  Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species.

Authors:  Chien-Ching Hung; Yun-Liang Yang; Tsai-Ling Lauderdale; L Clifford McDonald; Chin-Fu Hsiao; Hsiao-Hsu Cheng; Yong An Ho; Hsiu-Jung Lo
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 7.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus.

Authors:  M McCullough; B Ross; P Reade
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central taiwan.

Authors:  Mao-Wang Ho; Yun-Liang Yang; Chih-Chao Lin; Chih-Yu Chi; Hui-Ting Chen; Po-Chang Lin; Li-Yun Hsieh; Chia-Hui Chou; Wen-Li Chu; Chiou-Pyng Wu; Tsai-Ling Lauderdale; Hsiu-Jung Lo
Journal:  Mycopathologia       Date:  2014-05-08       Impact factor: 2.574

10.  Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.

Authors:  D Sullivan; D Bennett; M Henman; P Harwood; S Flint; F Mulcahy; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.